SURGICAL OUTCOMES IN PATIENTS WITH BORDERLINE RESECTABLE PANCREATIC ADENOCARCINOMA AFTER NEOADJUVANT CHEMOTHERAPY AND FIDUCIAL TARGETED IGRT: AN INSTITUTIONAL EXPERIENCE

被引：0
|
作者：
Sharma, Manav
Singh, Shailendra
Rao, Bharat
Kirichenko, Alexander
Morrissey, Suzanne
Mitre, Marcia
Garg, Mrinal
Kumar, Ujjala
Kulkarni, Abhijit
Monga, Dulabh
Schiffman, Suzanne
Williams, Harry K.
Atkinson, Donald
Lupetin, Anthony
Dhawan, Manish
Thakkar, Shyam
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)31222-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1324
引用
收藏
页码：S276 / S277
页数：2
相关论文
共 50 条
  • [41] Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival
    J. Bart Rose
    Flavio G. Rocha
    Adnan Alseidi
    Thomas Biehl
    Ravi Moonka
    John A. Ryan
    Bruce Lin
    Vincent Picozzi
    Scott Helton
    Annals of Surgical Oncology, 2014, 21 : 1530 - 1537
  • [42] Extended Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer Demonstrates Promising Postoperative Outcomes and Survival
    Rose, J. Bart
    Rocha, Flavio G.
    Alseidi, Adnan
    Biehl, Thomas
    Moonka, Ravi
    Ryan, John A.
    Lin, Bruce
    Picozzi, Vincent
    Helton, Scott
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 (05) : 1530 - 1537
  • [43] Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
    Hill, Colin S.
    Rosati, Lauren M.
    Hu, Chen
    Fu, Wei
    Sehgal, Shuchi
    Hacker-Prietz, Amy
    Wolfgang, Christopher L.
    Weiss, Matthew J.
    Burkhart, Richard A.
    Hruban, Ralph H.
    De Jesus-Acosta, Ana
    Le, Dung T.
    Zheng, Lei
    Laheru, Daniel A.
    He, Jin
    Narang, Amol K.
    Herman, Joseph M.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (04) : 2456 - 2468
  • [44] Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy
    Barugola, Giuliano
    Partelli, Stefano
    Crippa, Stefano
    Capelli, Paola
    D'Onofrio, Mirko
    Pederzoli, Paolo
    Falconi, Massimo
    AMERICAN JOURNAL OF SURGERY, 2012, 203 (02) : 132 - 139
  • [45] Neoadjuvant Radiotherapy After (m)FOLFIRINOX for Borderline Resectable Pancreatic Adenocarcinoma: A TAPS Consortium Study
    Janssen, Quisette P.
    van Dam, Jacob L.
    Prakash, Laura R.
    Doppenberg, Deesje
    Crane, Christopher H.
    van Eijck, Casper H. J.
    Ellsworth, Susannah G.
    Jarnagin, William R.
    O'Reilly, Eileen M.
    Paniccia, Alessandro
    Reyngold, Marsha
    Besselink, Marc G.
    Katz, Matthew H. G.
    Tzeng, Ching-Wei D.
    Zureikat, Amer H.
    Koerkamp, Bas Groot
    Wei, Alice C.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (07): : 783 - +
  • [46] Impact of Institutional Adoption of Neoadjuvant Chemotherapy for Stage I Pancreatic Adenocarcinoma on Outcomes
    Dal Molin, Marco
    Blackburn, Kyle
    Johnson, Abree
    McArdle, Patrick
    Hu, Yinin
    Hanna, Nader
    Mullins, C. Daniel
    Williams, Richelle
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 389 - 389
  • [47] Patterns of Local Failure after Neoadjuvant Radiation For Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
    Rhieu, B. H.
    Han-Oh, S.
    Guss, Z. D.
    Cheng, Z.
    Meyer, J. J.
    Herman, J. M.
    Narang, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E243 - E243
  • [48] Neoadjuvant chemotherapy with gemcitabine and S-1 for resectable and borderline pancreatic ductal adenocarcinoma: A prospective, multi-institutional, phase II trial
    Mizuma, Masamichi
    Motoi, Fuyuhiko
    Ishida, Kazuyuki
    Fujishima, Fumiyoshi
    Ottomo, Shigeru
    Oikawa, Masaya
    Okada, Takaho
    Shimamura, Hiromune
    Takemura, Shinichi
    Ono, Fuminori
    Akada, Masanori
    Nakagawa, Kei
    Katayose, Yu
    Egawa, Shinichi
    Unno, Michiaki
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [49] Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
    Colin S. Hill
    Lauren M. Rosati
    Chen Hu
    Wei Fu
    Shuchi Sehgal
    Amy Hacker-Prietz
    Christopher L. Wolfgang
    Matthew J. Weiss
    Richard A. Burkhart
    Ralph H. Hruban
    Ana De Jesus-Acosta
    Dung T. Le
    Lei Zheng
    Daniel A. Laheru
    Jin He
    Amol K. Narang
    Joseph M. Herman
    Annals of Surgical Oncology, 2022, 29 : 2456 - 2468
  • [50] Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borderline resectable pancreatic cancer
    Nakajima, Hiroki
    Yamaguchi, Junpei
    Takami, Hideki
    Hayashi, Masamichi
    Kodera, Yasuhiro
    Nishida, Yoshihiro
    Watanabe, Nobuyuki
    Onoe, Shunsuke
    Mizuno, Takashi
    Yokoyama, Yukihiro
    Ebata, Tomoki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (05) : 688 - 697
12345